Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Alison Gail Kartush, Jane K. Schumacher, Rachna Shah, et al.
American Journal of Rhinology and Allergy (2018) Vol. 33, Iss. 2, pp. 203-211
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
Tim Harrison, Pascal Chanez, Francesco Menzella, et al.
The Lancet Respiratory Medicine (2020) Vol. 9, Iss. 3, pp. 260-274
Open Access | Times Cited: 141
GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
Targeting NLRP3 Inflammasome Activation in Severe Asthma
Efthymia Theofani, Maria Semitekolou, Ioannis Morianos, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1615-1615
Open Access | Times Cited: 95
Clinically relevant phenotypes in chronic rhinosinusitis
Jessica W. Grayson, Marina Neves Cavada, Richard J. Harvey
Journal of Otolaryngology - Head and Neck Surgery (2019) Vol. 48, Iss. 1
Open Access | Times Cited: 86
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
Giorgio Walter Canonica, Tim Harrison, Pascal Chanez, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 150-161
Open Access | Times Cited: 55
Severe Asthmatic Responses: The Impact of TSLP
Efthymia Theofani, Aikaterini Tsitsopoulou, Ioannis Morianos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7581-7581
Open Access | Times Cited: 14
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Cysteinyl leukotriene metabolism of human eosinophils in allergic disease
Jun Miyata, Koichi Fukunaga, Yusuke Kawashima, et al.
Allergology International (2019) Vol. 69, Iss. 1, pp. 28-34
Open Access | Times Cited: 37
A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
William C. Brown, Brent A. Senior
Current Allergy and Asthma Reports (2020) Vol. 20, Iss. 6
Closed Access | Times Cited: 37
Benefits of biologic therapy administered for asthma on co‐existent chronic rhinosinusitis: A real‐world study
Shilpika Bajpai, Michael J. Marino, Matthew A. Rank, et al.
International Forum of Allergy & Rhinology (2021) Vol. 11, Iss. 8, pp. 1152-1161
Closed Access | Times Cited: 29
Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study
Juan M. Solano, M. Amparo Callejón, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 10, pp. 555-566
Closed Access | Times Cited: 12
How does asthma coexistence affect the strategic selection of biologic therapies in CRSwNP management?
İmran Özdemir, Nuray Bayar Muluk, Mustafa Yazır, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Smell impairment in patients with chronic rhinosinusitis: a real-life study
Giulio Cesare Passàli, Desiderio Passàli, Cemal Cingi, et al.
European Archives of Oto-Rhino-Laryngology (2021) Vol. 279, Iss. 2, pp. 773-777
Closed Access | Times Cited: 24
Critical Points on the Use of Biologicals in Allergic Diseases and Asthma
Ioana Agache, Cătălina Cojanu, Alexandru Laculiceanu, et al.
Allergy Asthma and Immunology Research (2019) Vol. 12, Iss. 1, pp. 24-24
Open Access | Times Cited: 27
Predictors of Disease Control After Endoscopic Sinus Surgery Plus Long-Term Local Corticosteroids in CRSwNP
Eugenio De Corso, Stefano Settimi, Laura Tricarico, et al.
American Journal of Rhinology and Allergy (2020) Vol. 35, Iss. 1, pp. 77-85
Closed Access | Times Cited: 27
Targeting eosinophils: severe asthma and beyond
Marco Caminati, Francesco Menzella, Lucia Guidolin, et al.
Drugs in Context (2019) Vol. 8
Open Access | Times Cited: 25
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Emma Kotisalmi, Auli Hakulinen, Mika J. Mäkelä, et al.
Asthma Research and Practice (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 22
Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
John V Boyle, Kent Lam, Joseph K. Han
Immunotherapy (2020) Vol. 12, Iss. 2, pp. 111-121
Closed Access | Times Cited: 21
Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion
Kyle Huntley, Joshua Raber, Lauren Fine, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 20
Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice
Yeon‐Hee Joo, Hyun‐Jin Cho, Yung Jin Jeon, et al.
The Laryngoscope (2020) Vol. 131, Iss. 5
Closed Access | Times Cited: 15
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients
Francesco Bandi, Stefania Gallo, Andrea Preti, et al.
Acta Otorhinolaryngologica Italica (2020) Vol. 40, Iss. 6, pp. 435-443
Open Access | Times Cited: 13
Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
Matteo Trimarchi, Pietro Indelicato, Alessandro Vinciguerra, et al.
Clinical Case Reports (2021) Vol. 9, Iss. 3, pp. 1428-1432
Open Access | Times Cited: 12
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic
Luciana Kase Tanno, P. Démoly, Bryan Martin, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 2, pp. 100515-100515
Open Access | Times Cited: 12
Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil
Wilma Terezinha Anselmo‐Lima, Edwin Tamashiro, Fabrizio Ricci Romano, et al.
Brazilian Journal of Otorhinolaryngology (2021) Vol. 88, Iss. 3, pp. 471-480
Open Access | Times Cited: 12
Role of Vitamin D in the Clinical Course of Nasal Polyposis
Giuseppe Murdaca, Francesca Paladin, Sebastiano Gangemi
Biomedicines (2021) Vol. 9, Iss. 8, pp. 855-855
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top